Philip Radovic, D.P.M. (born 27 March 1958) is a professor and podiatric surgeon practicing in South Orange County, California.

Early life and education edit

Radovic spent his formative years moving between various locations, primarily in northern California, but also residing in Ottawa, Canada, and Rio de Janeiro, Brazil. He obtained his degree in Molecular Cellular and Developmental Biology from the University of Colorado, Boulder, in 1982. During his undergraduate studies, Radovic was a founding member of the Lake Eldora Handicapped Ski Program. He also volunteered at the People's Clinic in Boulder, and worked as a Mental Health counselor at the Boulder Psychiatric Institute before pursuing his Doctorate in Podiatric Medicine at the California College of Podiatric Medicine, which he completed in 1987. During his 4th Year of Podiatric Medical Education, he participated in rotations at County-USC Medical Center in Los Angeles.

Career edit

After completing a two-year foot and ankle reconstructive surgical residency in 1989, Radovic established his private practice in San Clemente, California. In 1996, he founded and directed the Podiatric Medical and Surgical Residency Program at Aestheticare, also known as the Mission Hospital Regional Medical Center or SouthWestern Podiatric Medical and Surgical (PM&S-36).

Radovic served as a physician volunteer for Liga International, a non-profit organization that provides free healthcare to individuals living in poverty in Mexico, as well as Operation Footprint (formerly known as the Baja Crippled Children's Project). He also volunteered for earthquake relief in Nepal.

Dr. Radovic has also appeared as an on-air medical consultant on the nationally syndicated show, The Doctors.[1]

Research edit

Radovic served as the lead instructor for the use of AbobotulinumtoxinA in the management of hallux valgus in adult patients. He conducted a randomized and placebo-controlled Phase 2 trial for this treatment. Radovic also led a Phase IIa study on the use of Dysport in hallux abducto valgus (HAV).[2]

Publications edit

  • In 2003, Radovic co-authored a published study titled "Revisiting Epinephrine in Foot Surgery" in the Journal of the American Podiatric Medical Association. The study explored the benefits of using anesthetics containing epinephrine for foot surgery.[3]
  • In 2007, Radovic co-authored a published study that introduced a new modification to the Youngswick procedure, a surgical technique for correcting hallux limitus deformity.[4]
  • As a Fellowship Director at SouthWestern Podiatric Sports Medicine,[5] Radovic reviewed a publication titled "Bone Marrow Edema Lesions in the Professional Runner," which was published in the American Journal of Sports Medicine in 2014.[6]
  • In 1989, Radovic co-authored a study titled "Volume Injection Adhesiotomy," published in the Journal of the American Podiatric Medical Association, which described a novel approach to treating painful post-surgical adhesions.[7]
  • In 1990, Radovic co-authored a manuscript titled "Tarsal Tunnel Syndrome, Comprehensive Review of 87 Cases," published in the Journal of the American Podiatric Medical Association.[8]
  • In 1990, Radovic co-authored a manuscript titled "Use of the Subcutaneous Tissue Expander for Delayed Primary Closure of Flaps," published in the Journal of Foot Surgery.[9]
  • In 2008, Radovic authored a study titled "Nonsurgical Treatment for Hallux Abducto Valgus with Botulinum Toxin A," published in the Journal of the American Podiatric Medical Association, which described a novel method for treating painful hallux valgus (bunion) deformities using botulinum toxin.[10]
  • In 2020, Radovic authored a study titled "Nonsurgical Treatment for Hallux Abducto Valgus with Botulinum Toxin A - An Improvement of the Injection Paradigm," published in the Journal of the American Podiatric Medical Association, which presented an improved approach to treating painful hallux valgus deformities with botulinum toxin.[11]
  • In 2020, Radovic authored a study titled "Treatment of "plantar fasciitis"/Plantar Heel Pain Syndrome with botulinum toxin- A novel injection paradigm pilot study" in the journal The Foot. This study described a novel treatment method for heel pain syndrome of various causes.[12]

Patents edit

  • Radovic, Phillip. (2020). "Methods of Treating Abnormalities of the First metatarsophalangeal joint of the Foot." United States Patent 10,869,914. Filed January 3, 2020, and issued December 22, 2020.[13]
  • Radovic, Phillip. (2020). "Methods of Treating Pain Associated with Abnormalities of the First metatarsophalangeal joint of the Foot." United States Patent 10,525,112. Filed November 1, 2018, and issued January 7, 2020.[14]
  • Radovic, Phillip. (2018). "Methods of Treating Abnormalities of the First metatarsophalangeal joint of the Foot." United States Patent 10,159,723. Filed March 9, 2018, and issued December 25, 2018.[15]
  • Radovic, Phillip. (2020). "Functional Orthotic Support Structure for Footwear." United States Patent 10,667,574. Filed July 1, 2019, and issued June 2, 2020.[16]
  • Radovic, Phillip. (2020). "Plantar Heel Pain Syndrome Treatment." United States Patent 10,561,715. Filed November 27, 2018, and issued February 18, 2020.[17]
  • Radovic, Phillip. (2007). "Methods of Treating Abnormalities of the First metatarsophalangeal joint of the Foot." United States Patent 7,276,244. Filed February 11, 2005, and issued October 2, 2007.[18]

References edit

  1. ^ "Dr. Philip Radovic". The Doctors TV Show. Retrieved 10 March 2016.
  2. ^ Clinical trial number NCT03569098 for "Dysport in Hallux Abducto Valgus (HAV) Phase IIa (DYSTANCE)" at ClinicalTrials.gov
  3. ^ Radovic, Philip; Smith, Robert G.; Shumway, Don (1 March 2003). "Revisiting Epinephrine in Foot Surgery". Journal of the American Podiatric Medical Association. 93 (2): 157–160. doi:10.7547/87507315-93-2-157. PMID 12644524.
  4. ^ Radovic, Philip; Yadav-Shah, Ekta; Choe, Ki (1 September 2007). "Modified Youngswick Procedure for Hallux Limitus". Journal of the American Podiatric Medical Association. 97 (5): 420–423. doi:10.7547/0970420. PMID 17901350.
  5. ^ "SouthWestern Podiatric Surgical Sports Medicine Fellowship". ACFAS.org. Retrieved 10 March 2016.
  6. ^ Kornaat, Peter R.; Van de Velde, Samuel K. (May 2014). "Bone Marrow Edema Lesions in the Professional Runner". The American Journal of Sports Medicine. 42 (5): 1242–1246. doi:10.1177/0363546514521990. PMID 24557860. S2CID 25202937.
  7. ^ Grumbine, NA; Radovic, PA (1 March 1989). "Volume injection adhesiotomy". Journal of the American Podiatric Medical Association. 79 (3): 121–123. doi:10.7547/87507315-79-3-121. PMID 2656992.
  8. ^ Grumbine, NA; Radovic, PA; Parsons, R; Scheinin, GS (1 September 1990). "Tarsal tunnel syndrome. Comprehensive review of 87 cases". Journal of the American Podiatric Medical Association. 80 (9): 457–461. doi:10.7547/87507315-80-9-457. PMID 2231354.
  9. ^ Santoro, JP; Radovic, PA; Grumbine, NA (May 1989). "Use of the subcutaneous tissue expander for delayed primary closure of flaps". The Journal of Foot Surgery. 28 (3): 225–32. PMID 2576272.
  10. ^ Radovic, PA; Shah, E (January 2008). "Nonsurgical treatment for hallux abducto valgus with botulinum toxin A". Journal of the American Podiatric Medical Association. 98 (1): 61–5. PMID 18202336.
  11. ^ Radovic, Philip Andrew (1 March 2020). "Nonsurgical Treatment for Hallux Abducto Valgus with Botulinum Toxin Type A". Journal of the American Podiatric Medical Association. 110 (2): Article_6. doi:10.7547/18-132. PMID 32556234. S2CID 219923322.
  12. ^ Radovic, Philip (December 2020). "Treatment of 'plantar fasciitis'/Plantar Heel Pain Syndrome with botulinum toxin — A novel injection paradigm pilot study". The Foot. 45: 101711. doi:10.1016/j.foot.2020.101711. PMID 33038660. S2CID 222280526.
  13. ^ "Patent Images".
  14. ^ "Patent Images".
  15. ^ "Patent Images".
  16. ^ "Patent Images".
  17. ^ "Patent Images".
  18. ^ "Patent Images".

External links edit